September 7, 2015Open Access
View Full PaperEffects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Structured PICO
Does empagliflozin reduce blood pressure and improve markers of arterial stiffness and vascular resistance in patients with type 2 diabetes?
P
Population
Patients with type 2 diabetes
I
Intervention
Empagliflozin
O
Outcome
Blood pressure, markers of arterial stiffness, and vascular resistancesurrogate
Empagliflozin improves blood pressure and markers of vascular health in patients with type 2 diabetes.
Abstract
Empagliflozin reduced BP and had favourable effects on markers of arterial stiffness and vascular resistance.